Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Florida for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Florida only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Florida (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Southern Quest LLC (NPI 1033820899)

Key Findings

Field	Value
Entity Type	Organization
Organization	Southern Quest LLC
Address	1500 Nw 62nd St Ste 406
City	Ft Lauderdale
State	FL
ZIP	33309
Taxonomy	Clinical Medical Laboratory
NPI Enumerated	December 12, 2022

Payer Source	Total Paid
Medicare	$10.9M
Medicaid	$0

Service line: SOUTHERN QUEST LLC operates as a clinical molecular/genetic testing laboratory focused on germline and cancer‑related sequencing and deletion/duplication analyses, as evidenced by heavy Medicare billing for BRCA1/2 (81162), PTEN (81321), PALB2 (81307) and multiple mismatch repair and cancer predisposition genes (MLH1, MSH2, MSH6, PMS2, TP53). The top CPT/HCPCS codes are all sequence‑level or large rearrangement assays, indicating the business is centered on high‑complexity genetic diagnostics rather than routine chemistry or anatomic pathology services.

Revenue concentration: The provider’s Medicare business is materially concentrated in a small set of high‑value genetic tests — the precomputed top 3 Medicare codes account for 32.5% of total Medicare revenue. Those top three codes are 81162 ($1.6M revenue, 15.3% of this provider's total Medicare revenue), 81321 ($899.1K revenue, 8.7%), and 81307 ($894.4K revenue, 8.6%), showing a reliance on a handful of sequencing assays to drive a large share of revenue.

Payer mix: SOUTHERN QUEST LLC is effectively single‑payer on file — reported Medicare lifetime revenue is $10.9M while Medicaid billing is listed as none (no Medicaid billing on file). This concentration on Medicare reduces exposure to Medicaid reimbursement variability but also means the provider currently has no Medicaid claims footprint to support state‑level contracting or pediatric/dual‑eligible patient capture.

Competitive standing — national leaders on select tests: The practice is a national leader on several specialized assays, with 81162 ranking #1 of 35 providers nationally (100th percentile; extreme outlier, far above typical national volume for this code) and 81292 ranking #1 of 20 providers nationally (100th percentile; extreme outlier). Multiple other codes are also top‑ranked or at the 100th percentile (for example, 81323 ranks #1 of 5 providers nationally and 81295 ranks #1 of 34 providers nationally), indicating outsized national share on several niche hereditary cancer tests.

Competitive standing — broader portfolio: Outside its headline outlier codes, many of SOUTHERN QUEST’s commonly billed sequencing assays show solid but not dominant positions versus peers — for example 81321 ranks #8 of 37 providers nationally (81th percentile) and 81307 ranks #13 of 62 providers nationally (80th percentile). This pattern suggests the provider combines a small number of nationally dominant tests with a broader set of typical‑volume offerings to capture referrals across multiple gene targets.

Reimbursement profile and case mix: Some high‑revenue codes combine both high per‑claim payment and substantial volume, for example 81162 shows 886 claims with an average paid/claim of $1788 and $1.6M total revenue, while other high‑revenue codes achieve scale through larger claim counts at lower average payments (for example 81321 with 1.5K claims at $588 avg paid/claim). The mix of expensive, low‑volume assays and mid‑priced, high‑volume assays is consistent with a specialized genomic lab performing both full‑gene sequencing and targeted tests.

Tenure and growth signal: The NPI was enumerated 2022-12-12 (~4 years ago), so the organization is relatively recently registered yet already reports $10.9M in Medicare lifetime revenue and national leading volumes on several codes. Achieving national outlier status on specific assays within ~4 years suggests rapid growth or aggregation of referral volume for those assays.

Market implications — contracting and expansion: The absence of any Medicaid billing (none (no Medicaid billing on file)) limits the provider’s participation in state Medicaid networks and may constrain access to Medicaid populations; conversely, the laboratory’s national leadership on certain hereditary cancer tests creates leverage for payers seeking high‑volume specialist capacity in genetic diagnostics. For payers and providers evaluating network strategy, SOUTHERN QUEST represents a strong Medicare‑focused genetic testing partner but not currently a Medicaid participant.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

32 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
81162	The lab analyst performs the technical lab test to analyze the entire gene sequence for the BRCA1, DNA repair–associated gene, also called BRCA1; and BRCA2, DNA repair–associated gene, also called…	890	$1,790	$1.6M
81321	The lab analyst performs the technical lab test to analyze the entire gene sequence for the phosphatase and tensin homolog, or PTEN, gene.	1,530	$590	$899.1K
81307	The lab analyst performs the technical lab test on a specimen such as blood, to analyze the entire gene sequence for the partner and localizer of BRCA2 (PALB2) gene.	1,350	$660	$894.4K
81351	The lab analyst performs the technical lab test on a specimen such as blood to analyze the entire gene sequence for the tumor protein 53 (TP53) gene, which may indicate a diagnosis of Li–Fraumeni…	1,100	$630	$694.4K
81292	The lab analyst performs the technical lab test to analyze the entire gene sequence for the mutL homolog 1, or MLH1 gene, also known as the colon cancer or nonpolyposis type 2 gene.	1,030	$660	$684.5K
81317	The lab analyst performs the technical lab test to analyze the entire gene sequence for the postmeiotic segregation increased 2 [S. cerevisiae], or PMS2 gene.	870	$660	$573.5K
81298	The lab analyst performs the technical lab test to analyze the entire gene sequence for the mutS homolog 6 [E. coli], or MSH6 gene.	870	$630	$549.1K
81323	The lab analyst performs the technical lab test to detect genetic changes involving long sequences of deleted or duplicated DNA in the gene for the phosphatase and tensin homolog, or PTEN, gene.	1,620	$290	$476.9K
81295	The lab analyst performs the technical lab test to analyze the entire gene sequence for the mutS homolog 2, or MSH2 gene, also known as the colon cancer or nonpolyposis type 1 gene.	960	$370	$357.5K
81272	The lab analyst performs the technical lab test for a partial gene sequence analysis for the v–kit Hardy–Zuckerman 4 feline sarcoma viral oncogene homolog, or KIT, gene. The analysis does not analyze…	1,100	$320	$356.6K

Showing 1–10 of 32

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Maxim Healthcare Services, Inc.	FL	Home Health Agency	$0	$29.9M
Pediatric Services Of America, LLC	FL	Nursing Care Agency	$0	$18.1M
Galaxy Medical Inc	FL	Durable Medical Equipment & Medical Supplies	$0	$11.6M
Senior Nannies Home Care Services, LLC	FL	Nursing Care Agency	$0	$10.8M
Charles Aiesi Consulting. Inc.	FL	Clinical Medical Laboratory	$2.1M	$480.6K
Dania Discount Drugs Inc	FL	Community/Retail Pharmacy	$1.9M	$342K
Barry Charnick	FL	Nuclear Radiology Physician	$1.3M	$0
Cypress Creek Outpatient Surgical Center, LLC	FL	Ambulatory Surgical Clinic/Center	$797K	$0
Reva, Inc.	FL	Air Ambulance	$275.7K	$471K
Alan Perlmutter	FL	Radiation Oncology Physician	$723.7K	$0

Southern Quest LLC — Billing Profile & Reimbursement Data

Sign up for Southern Quest LLC — Billing Profile & Reimbursement Data policy alerts

Southern Quest LLC — Billing Profile & Reimbursement Data

Sign up for Southern Quest LLC — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Nearby Providers

Frequently Asked Questions

References

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
81307	7	30	320	$660	$508.3K
81321	7	30	430	$580	$467.7K
81238	9	20	330	$590	$440.3K
81162	1	20	100	$1,780	$403.3K
81249	8	20	290	$590	$383.1K
81223	8	20	340	$490	$329.3K
81351	3	20	210	$630	$307.8K
81334	8	20	390	$320	$295.7K
81323	1	10	470	$290	$229.2K
81311	7	20	270	$290	$213K